Bruce F Wesson insider trades: Acura Pharmaceuticals (ACUR) stock buys and sales

Director, Acura Pharmaceuticals Last trade Dec 14, 2017 86 Form 4 filings

Sold, last 12 months

0 sales

Bought, last 12 months

0 buys

Open-market trades

since 2006

Companies

last trade 2017

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Bruce reports to the SEC

ACURAcura Pharmaceuticals

Director · last filing Jan 2, 2024

+$169K

DSCIDerma Sciences

Insider · last filing Jun 2, 2016

-$2.4M

+$257K

MDASMedassets

Director · last filing Jan 27, 2016

-$29.6M

+$225K

SHPISpecialized Health Products International

10% Owner · last filing Jun 10, 2008

-$15.4M

CEMChemtura

Director · last filing Mar 4, 2008

No market trades

ACPHAcura Pharmaceuticals

Director · last filing Jan 28, 2008

No market trades

and 2 more companies

Open-market buys and sales

74 trades reported on SEC Form 4, newest first

Date	Stock	Type	Shares	Price	Value	Holding	Reported
Dec 14, 2017	ACURAcura Pharmaceuticals	↑ Buy	335,734	$0.10	$34K	Direct	Dec 15, 2017 (1d)
Aug 13, 2015	DSCIDerma Sciences	↑ Buy	10,000	$6.58	$66K	Direct	Aug 14, 2015 (1d)
May 16, 2014	ACURAcura Pharmaceuticals	↑ Buy	80,000	$1.13	$90K	Direct	May 16, 2014 (0d)
Nov 21, 2013	MDASMedassets	↓ Sell	60,263	$20.54	$1.2M	Direct	Nov 22, 2013 (1d)
Nov 23, 2011	MDASMedassets	↑ Buy	24,000	$9.36	$225K	Direct	Nov 28, 2011 (5d)
Nov 23, 2011	DSCIDerma Sciences	↑ Buy	10,000	$7.51	$75K	Direct	Nov 28, 2011 (5d)
Sep 6, 2011	DSCIDerma Sciences	↑ Buy	10,000	$8.08	$81K	Direct	Sep 9, 2011 (3d)
Aug 19, 2011	ACURAcura Pharmaceuticals	↑ Buy	14,904	$3.05	$45K	Direct	Aug 23, 2011 (4d)
May 13, 2011	MDASMedassets	↓ Sell	77,500	$16.06	$1.2M	See FN	May 16, 2011 (3d)
Feb 16, 2011	DSCIDerma Sciences	↓ Sell	73,552	$10.16	$747K	See FN	Feb 17, 2011 (1d)
Feb 11, 2011	DSCIDerma Sciences	↓ Sell	128,220	$12.54	$1.6M	See FN	Feb 14, 2011 (3d)
Oct 26, 2010	MDASMedassets	↓ Sell	66,041	$22.27	$1.5M	See FN	Oct 27, 2010 (1d)
Oct 22, 2010	MDASMedassets	↓ Sell	52,525	$22.10	$1.2M	See FN	Oct 22, 2010 (0d)
Aug 23, 2010	MDASMedassets	↓ Sell	990	$24.06	$24K	See FN	Aug 25, 2010 (2d)
Jul 27, 2010	MDASMedassets	↓ Sell	66,920	$24.19	$1.6M	See FN	Jul 27, 2010 (0d)
Jul 21, 2010	MDASMedassets	↓ Sell	33,450	$24.07	$805K	See FN	Jul 21, 2010 (0d)
Jun 21, 2010	MDASMedassets	↓ Sell	111,708	$24.15	$2.7M	See FN	Jun 23, 2010 (2d)
May 18, 2010	MDASMedassets	↓ Sell	30,856	$24.11	$744K	See FN	May 19, 2010 (1d)
Apr 26, 2010	MDASMedassets	↓ Sell	111,708	$22.24	$2.5M	See FN	Apr 26, 2010 (0d)
Mar 23, 2010	MDASMedassets	↓ Sell	42,373	$22.13	$938K	See FN	Mar 23, 2010 (0d)
Mar 18, 2010	MDASMedassets	↓ Sell	8,818	$22.06	$195K	See FN	Mar 18, 2010 (0d)
Nov 2, 2009	MDASMedassets	↓ Sell	55,584	$22.11	$1.2M	Indirect	Nov 3, 2009 (1d)
Oct 8, 2009	MDASMedassets	↓ Sell	15,199	$22.06	$335K	Indirect	Oct 13, 2009 (5d)
Oct 6, 2009	MDASMedassets	↓ Sell	10,047	$22.06	$222K	Indirect	Oct 7, 2009 (1d)
Oct 2, 2009	MDASMedassets	↓ Sell	30,608	$22.12	$677K	Indirect	Oct 5, 2009 (3d)
Sep 15, 2009	MDASMedassets	↓ Sell	55,854	$22.19	$1.2M	Indirect	Sep 17, 2009 (2d)
Aug 3, 2009	MDASMedassets	↓ Sell	41,346	$19.00	$786K	By Galen Partners III, L.P.	Aug 5, 2009 (2d)
Aug 3, 2009	MDASMedassets	↓ Sell	9,824	$19.00	$187K	By Galen Partners IV, L.P.	Aug 5, 2009 (2d)
Aug 3, 2009	MDASMedassets	↓ Sell	3,747	$19.00	$71K	By Galen Partners International III, L.P	Aug 5, 2009 (2d)
Aug 3, 2009	MDASMedassets	↓ Sell	780	$19.00	$15K	By Galen Partners International IV, L.P.	Aug 5, 2009 (2d)
Aug 3, 2009	MDASMedassets	↓ Sell	142	$19.00	$3K	By Galen Employee Fund III, L.P.	Aug 5, 2009 (2d)
Aug 3, 2009	MDASMedassets	↓ Sell	11	$19.00	$209	By Galen Employee Fund IV, L.P.	Aug 5, 2009 (2d)
Jul 1, 2009	MDASMedassets	↓ Sell	41,346	$19.16	$792K	By Galen Partners III, L.P.	Jul 2, 2009 (1d)
Jul 1, 2009	MDASMedassets	↓ Sell	9,825	$19.16	$188K	By Galen Partners IV, L.P.	Jul 2, 2009 (1d)
Jul 1, 2009	MDASMedassets	↓ Sell	3,747	$19.16	$72K	By Galen Partners International III, L.P	Jul 2, 2009 (1d)
Jul 1, 2009	MDASMedassets	↓ Sell	780	$19.16	$15K	By Galen Partners International IV, L.P.	Jul 2, 2009 (1d)
Jul 1, 2009	MDASMedassets	↓ Sell	142	$19.16	$3K	By Galen Employee Fund III, L.P.	Jul 2, 2009 (1d)
Jul 1, 2009	MDASMedassets	↓ Sell	14	$19.16	$268	By Galen Employee Fund IV, L.P.	Jul 2, 2009 (1d)
Jun 10, 2009	MDASMedassets	↓ Sell	41,346	$17.06	$705K	By Galen Partners III, L.P.	Jun 17, 2009 (7d)
Jun 10, 2009	MDASMedassets	↓ Sell	9,825	$17.06	$168K	By Galen Partners IV, L.P.	Jun 17, 2009 (7d)
Jun 10, 2009	MDASMedassets	↓ Sell	3,747	$17.06	$64K	By Galen Partners International III, L.P	Jun 17, 2009 (7d)
Jun 10, 2009	MDASMedassets	↓ Sell	780	$17.06	$13K	By Galen Partners International IV, L.P.	Jun 17, 2009 (7d)
Jun 10, 2009	MDASMedassets	↓ Sell	142	$17.06	$2K	By Galen Employee Fund III, L.P.	Jun 17, 2009 (7d)
Jun 10, 2009	MDASMedassets	↓ Sell	14	$17.06	$239	By Galen Employee Fund IV, L.P.	Jun 17, 2009 (7d)
May 1, 2009	MDASMedassets	↓ Sell	41,346	$16.36	$676K	By Galen Partners III, L.P.	May 5, 2009 (4d)
May 1, 2009	MDASMedassets	↓ Sell	9,825	$16.36	$161K	By Galen Partners IV, L.P.	May 5, 2009 (4d)
May 1, 2009	MDASMedassets	↓ Sell	3,747	$16.36	$61K	By Galen Partners International III, L.P	May 5, 2009 (4d)
May 1, 2009	MDASMedassets	↓ Sell	780	$16.36	$13K	By Galen Partners International IV, L.P.	May 5, 2009 (4d)
May 1, 2009	MDASMedassets	↓ Sell	142	$16.36	$2K	By Galen Employee Fund III, L.P.	May 5, 2009 (4d)
May 1, 2009	MDASMedassets	↓ Sell	14	$16.36	$229	By Galen Employee Fund IV, L.P.	May 5, 2009 (4d)

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Bruce F Wesson's insider trades

Bruce F Wesson is a director at Acura Pharmaceuticals (ACUR). Since Nov 3, 2006, Bruce has reported 8 open-market purchases worth $651K and 66 sales worth $48.5M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (38 filings), option exercises (14 filings), other transactions (8 filings), shares returned to the company (2 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ACUR insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.